![]() |
市場調查報告書
商品編碼
1859896
醫用導管:全球市場佔有率和排名、總銷售額和需求預測(2025-2031 年)Medical Catheters - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
全球醫用導管市場預計在 2024 年達到 308.55 億美元,預計到 2031 年將達到 452.38 億美元,2025 年至 2031 年的複合年成長率為 5.7%。
本報告對近期關稅調整和國際策略反制措施對醫用導管跨境產業佈局、資本配置模式、區域經濟相互依存關係和供應鏈重組的影響進行了全面評估。
醫用導管是一種插入人體、體腔或血管的醫療設備,用於輸注液體或藥物、排放液體、監測生理參數或提供路徑。依應用領域分類,醫用導管可分為心血管導管、泌尿系統、神經血管導管、靜脈導管和特殊用途導管。依材料分類,醫用導管可分為矽膠導管、聚氨酯(PU)導管、聚氯乙烯(PVC)導管、氟聚合物導管和高性能醫用聚合物導管。依使用時間和置入方式分類,醫用導管可進一步分為短期一次性導管和長期留置導管。醫用導管在微創手術、透析、泌尿系統管理、介入性介入心臟病學、加護治療和居家醫療中至關重要。關鍵設計要求包括生物相容性、耐化學性、柔韌性和抗菌性能,在某些情況下,還需要整合可視化和感測器。預計2024年,全球醫用導管產量將達到約61.77億支,全球平均市場價格約為每支5美元。
目前,醫用導管產業正處於快速成長階段,多種促進因素為執行長、市場經理和投資者提供了明確的機會。首先,全球慢性心血管疾病、泌尿系統、腎臟疾病和神經系統疾病的發生率持續上升,為用於診斷和治療的導管產品創造了穩定且不斷成長的需求基礎。其次,人口老化顯著增加了泌尿系統管理、長期靜脈通路和透析等領域對導管的需求。第三,醫療技術創新(尤其是微創手術、干涉導管以及整合可視化和感測器的導管)為高附加價值和差異化提供了機會。第四,醫療費用支出不斷成長、保險報銷政策不斷擴大以及公共衛生投資不斷增加,提高了高性能和功能性導管的接受度,並降低了部分地區的市場准入門檻。第五,對感染控制、一次性或塗層導管以及可生物分解或環保材料的監管和環境要求不斷提高,創造了新的需求成長點。這些因素綜合起來,為醫療導管市場在產品類型、材料複雜性、服務擴展(居家醫療、遠端醫療)和地理擴展(新興市場)方面提供了巨大的成長空間。
儘管醫療導管產業蘊藏著許多機遇,但也面臨嚴峻的挑戰與風險。首先,感染風險和導管相關併發症(例如,導管相關性尿道感染和中央靜脈導管相關性血流感染疾病)仍然是主要的臨床問題。除非產品能夠透過塗層、滅菌和設計(一次性使用與可重複使用)顯著降低風險,否則其市場信譽和監管核准可能會受到限制。其次,高階導管產品高成本,需要大量的研發投入,並涉及複雜的材料和製造流程。某些市場對價格的敏感度以及高階和新型技術導管缺乏報銷機制可能會限制其普及。第三,監管和品質標準不斷加強。生物相容性、毒性、物理性能、滅菌驗證、註冊和核准的要求日益嚴格,尤其是在已開發國家和歐盟。這些監管流程耗時且高成本,為中小企業帶來了沉重的負擔。第四,原料價格波動和供應不穩定(尤其是高性能聚合物、特殊塗料和進口材料)對成本結構和前置作業時間有顯著影響。第五,新興市場雖然提供了快速成長的機會,但也面臨著基礎設施不足、外科和介入人員技能水平有限、報銷體系緩慢以及採購結構分散等挑戰,導致市場進入和規模擴張速度較慢,且資本投入更高。
在下游臨床和終端使用者層面,醫用導管的結構和功能需求正在不斷演變。首先,醫院和介入手術中心越來越需要微創、快速更換以及導航或影像引導的導管,以縮短手術時間、減少病患創傷並提高操作者的靈活性。其次,居家醫療和遠端醫療環境越來越需要一次性導管、可自行導尿、易於使用且維護成本低的導管,患者的舒適度和衛生狀況也成為關鍵的產品差異化因素。第三,對連結性和智慧功能的需求日益成長。具備感測功能、壓力監測、溫度和流量回饋、進階視覺化以及與數位醫療系統整合等特性的導管正成為優先考慮的因素。第四,日益成長的環境和永續性問題推動了對可生物分解材料、不含鄰苯二甲酸二辛酯(DEHP)、不含乳膠或低過敏性材料、減少廢棄物以及可回收包裝的需求,這些正日益成為關鍵的採購標準。第五,下游採購管道在不同地區也在改變。已開發經濟體正在走向集中採購、報銷和標準化競標系統,而新興市場正在透過公私合營、政策主導的公共醫療設施擴張、門診手術中心 (ASC)、居家醫療以及電子商務管道日益成長的重要性,重塑需求到達製造商的方式。
醫用導管的上游原料主要包括醫用聚合物(矽膠、聚氨酯(PU)、聚氯乙烯(PVC)、氟聚合物以及更先進的醫用塑膠,例如聚醚醚酮(PEEK)和醫用級聚碸)、被覆劑和抗菌劑(銀塗層、抗生物膜塗層、親水/滑動塗層)、金屬組件(例如導管包裝器和某些連接器的連接管)。每種材料類別都有不同的市場特性和相關風險。該產品的平均毛利率為52%。
本報告旨在按地區/國家、類型和應用對全球醫用導管市場進行全面分析,重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名。
醫療導管市場規模、估算和預測以銷售(百萬)和收入(百萬美元)為單位呈現,基準年為2024年,並包含2020年至2031年的歷史數據和預測數據。定量和定性分析將幫助讀者制定醫療導管業務和成長策略,評估市場競爭,分析自身在當前市場中的地位,並做出明智的商業決策。
市場區隔
公司
按類型分類的細分市場
應用領域
按地區
The global market for Medical Catheters was estimated to be worth US$ 30855 million in 2024 and is forecast to a readjusted size of US$ 45238 million by 2031 with a CAGR of 5.7% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Medical Catheters cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Medical catheters are medical devices inserted into the human body or body cavities or vessels to deliver fluids or medications, drain body fluids, monitor physiological parameters, or provide access channels. They are classified by use into cardiovascular, urological, neurovascular, intravenous, and specialty catheters; by materials such as silicone, polyurethane (PU), polyvinyl chloride (PVC), fluoropolymers, or high-performance medical polymers; and by duration or implantation mode into short-term disposable vs. long-term implanted types. They are essential in contexts such as minimally invasive surgeries, dialysis, urinary management, cardiovascular interventions, critical care, and home healthcare. Key design requirements include biocompatibility, chemical resistance, flexibility, antimicrobial properties, and in some cases visualization or sensor integration.In 2024, global Medical catheters production reached approximately 6177 m units, with an average global market price of around US$ 5 perunit.
The medical catheter industry is currently in a rapid growth phase, with multiple driving forces presenting clear opportunities for CEOs, marketing managers, and investors. First, the global incidence of chronic cardiovascular diseases, urinary and renal disorders, and neurological conditions continues to rise, creating a stable and expanding demand base for catheter products used in diagnosis and treatment. Second, demographic aging significantly increases catheter needs in areas such as urinary management, long-term venous access, and dialysis. Third, innovation in medical technologies-especially minimally invasive surgery, interventional catheterization, visualization-enabled and sensor-integrated catheters-offers high value-add and differentiation opportunities. Fourth, rising healthcare expenditure, enhanced insurance reimbursement policies, and public health investment are improving acceptance of premium and functional catheters, lowering entry barriers in some regions. Fifth, increasing regulatory and environmental demands for infection control, disposable or coated catheters, and biodegradable or low environmental-impact materials are creating new demand growth points. Combined, these factors make the medical catheter market fertile for expansion across product types, material upgrades, service extension (home care, telemedicine), and geographic reach (emerging markets).
While numerous opportunities exist, the medical catheter industry faces significant challenges and risks. First, infection risk and catheter-related complications (such as catheter-associated urinary tract infections, central line-associated bloodstream infections) remain major clinical concerns; unless products meaningfully reduce risk via coatings, sterilization, and design (disposable vs reusable), market reputation and regulatory approvals may be constrained. Second, high-end catheter products have high costs, require large R&D investment, and involve complex materials and manufacturing processes; pricing sensitivity in some markets, and lack of reimbursement for premium or novel technology catheters, may suppress adoption. Third, regulations and quality standards are continually rising-biocompatibility, toxicity, physical performance, sterilization validation, registration and approval are increasingly stringent-especially in developed economies and the EU; these regulatory pathways are long and expensive, putting pressure especially on small and medium firms. Fourth, raw material price volatility and supply instability-especially for high-performance polymers, specialized coatings, or imported materials-significantly affect cost structure and lead times. Fifth, although emerging markets offer fast growth, they often suffer from differences in infrastructure, skill level of surgical or interventional staff, lagging reimbursement systems, decentralized procurement, etc., which make market entry and scaling slower and more capital-intensive.
At the downstream clinical and end-user side, demand is undergoing structural and functional evolution in requirements for medical catheters. First, hospitals and interventional surgery centers are increasingly demanding minimally invasive catheters, quick-exchange types, navigation or imaging-guided catheters to reduce operating time, lower invasiveness for patients, and increase operator flexibility. Second, in home care and telemedicine settings, demand is growing for disposable catheters, self-catheterization, ease of use, low maintenance devices; patient comfort and hygiene have become key product differentiators. Third, connectivity and smart features are rising: catheters with sensing functions, pressure monitoring, temperature or flow feedback, visualized tips, and integration with digital health systems are being more prioritized. Fourth, environmental and sustainability concerns are pushing demand toward biodegradable materials, DEHP-free, latex-free or low allergen materials, reduced waste and recyclable packaging, which increasingly become procurement criteria. Fifth, regional downstream procurement channels are evolving: in developed countries, centralized purchasing, insurance reimbursement and standardized tendering systems are maturing; in emerging markets, public-private partnerships, policy-driven public health facility expansion, and increasing importance of outpatient surgery centers (ASCs), home care, and even e-commerce channels are reshaping how demand reaches manufacturers.
The upstream raw materials for medical catheters mainly include medical polymers (such as silicone, polyurethane (PU), PVC, fluoropolymers, and more advanced medical plastics like PEEK or medical-grade polysulfone), coating and antimicrobial agents (silver coatings, anti-biofilm coatings, hydrophilic/slip coatings), metallic components (in tips, support scaffolds or electrode parts of certain catheters), and auxiliary & packaging materials (sterile packaging, connectors, sealing components). Each material category exhibits distinct market characteristics and associated risks. The average gross profit margin of this product is 52%
This report aims to provide a comprehensive presentation of the global market for Medical Catheters, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Medical Catheters by region & country, by Type, and by Application.
The Medical Catheters market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Catheters.
Market Segmentation
By Company
Segment by Type
Segment by Application
By Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Medical Catheters manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Medical Catheters in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Medical Catheters in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.